You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

leukemia, myeloid chronic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

Not yet recruiting
  • Chronic Myelogenous Leukemia - Chronic Phase
  • APN and medical management
  • +3 more
  • Avignon, Provence-Alpes-Côte d'Azur, France
    Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
Oct 13, 2023

CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

Recruiting
  • CML, Chronic Phase
  • CML, Accelerated Phase
  • HS-10382(Part 1: Dose escalation)
  • HS-10382(Part 2: Dose expansion)
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Jan 12, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Metabolic Alternation and Clinicohematological Characteristic in

Not yet recruiting
  • CML, Chronic Phase
  • Tyrosine kinase inhibitor
  • (no location specified)
Nov 6, 2023

Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • +3 more
  • Augusta, Georgia
  • +1 more
Jul 14, 2022

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

Not yet recruiting
  • Leukemia
  • +12 more
  • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
  • (no location specified)
Mar 20, 2023

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Online Mindfulness Meditation
  • Internet-Based Webinars
  • San Francisco, California
    University of California San Francisco
Aug 9, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Hyperbaric oxygen
  • Rochester, New York
    Wilmot Cancer Institute, University of Rochester
May 16, 2022

New Diagnosed Chronic Phase Chronic Myeloid Leukemia

Recruiting
  • Validity and Safety
    • Guangzhou, Guangdong, China
      NanfangH
    Apr 9, 2022

    Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis
      Nov 20, 2023

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 15, 2022

      CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

      Not yet recruiting
      • CML, Chronic Phase
      • Harbin, Heilongjiang, China
        Institute of Hematology and Oncology, Harbin The First Hospital
      May 5, 2022

      Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

      Recruiting
      • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • Chronic Phase Chronic Myelogenous Leukemia
      • Text Message-Based Navigation Intervention
      • Survey Administration
      • Philadelphia, Pennsylvania
        Sidney Kimmel Cancer Center at Thomas Jefferson University
      Apr 7, 2022

      MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

      Not yet recruiting
      • Myelodysplastic Syndromes
      • +3 more
      • Subcutaneous azacitidine
      • Oral decitabine/cedazuridine
      • Newcastle, New South Wales, Australia
        Calvary Mater Newcastle
      May 29, 2023

      Ponatinib in CML Patients in Chronic Phase

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Therapeutic drug monitoring
      • Molecular Response
      • Cagliari, Italy
      • +4 more
      Nov 3, 2023

      Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

      Active, not recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
        • Jena, Germany
          University Hospital Jena
        Jan 17, 2023

        Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

        Recruiting
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +6 more
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 31, 2022

        Outcomes in Chronic Myeloid Leukaemia

        Completed
        • Chronic Myeloid Leukaemia
          • York, United Kingdom
            Haematological Malignancy Research Network
          Jun 7, 2023

          Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

          Recruiting
          • Chronic Phase Chronic Myelogenous Leukemia
          • Detroit, Michigan
          • +1 more
          May 3, 2022

          Myelofibrosis, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Charlottesville (Tagraxofusp)

          Recruiting
          • Myelofibrosis
          • +2 more
          • Charlottesville, Virginia
            Danyelle Coley
          Jan 18, 2023

          CML, Chronic Phase Trial in Harbin (Flumatinib mesylate tablets (400mg), Flumatinib mesylate tablets (600mg))

          Recruiting
          • CML, Chronic Phase
          • Flumatinib mesylate tablets (400mg)
          • Flumatinib mesylate tablets (600mg)
          • Harbin, Hei Longjiang, China
            Institute of Hematology and Oncology, Harbin The First Hospital
          Apr 28, 2022

          Leukemia,Myeloid, Chronic Trial in France (Blood and bone marrow sample)

          Not yet recruiting
          • Leukemia,Myeloid, Chronic
          • Blood and bone marrow sample
          • Annecy, France
          • +15 more
          Nov 10, 2023

          Leukemia, Myeloid, Chronic-Phase Trial in Germany (Ponatinib)

          Active, not recruiting
          • Leukemia, Myeloid, Chronic-Phase
          • Halle (Saale), Saxony-Anhalt, Germany
          • +9 more
          Sep 9, 2022